{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T15:07:26Z","timestamp":1785337646293,"version":"3.55.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T00:00:00Z","timestamp":1540339200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T00:00:00Z","timestamp":1540339200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5T32 A1007046 - 40"],"award-info":[{"award-number":["5T32 A1007046 - 40"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12879-018-3408-y","type":"journal-article","created":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T12:05:30Z","timestamp":1540382730000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":112,"title":["Rising rates of injection drug use associated infective endocarditis in Virginia with missed opportunities for addiction treatment referral: a retrospective cohort study"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9172-6821","authenticated-orcid":false,"given":"Megan E.","family":"Gray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth T.","family":"Rogawski McQuade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Michael","family":"Scheld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca A.","family":"Dillingham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,24]]},"reference":[{"issue":"10050","key":"3408_CR1","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/S0140-6736(16)30856-X","volume":"388","author":"FL Altice","year":"2016","unstructured":"Altice FL, Azbel L, Stone J, Brooks-Pollock E, Smyrnov P, Dvoriak S, Taxman FS, El-Bassel N, Martin NK, Booth R, Stover H, Dolan K, Vickerman P. The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia. Lancet. 2016;388(10050):1228\u201348.","journal-title":"Lancet"},{"issue":"47","key":"3408_CR2","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.15585\/mmwr.mm6547e1","volume":"65","author":"C Wejnert","year":"2016","unstructured":"Wejnert C, Hess KL, Hall HI, Van Handel M, Hayes D, Fulton P Jr, An Q, Koenig LJ, Prejean J, Valleroy LA. Vital signs: trends in HIV diagnoses, risk behaviors, and prevention among persons who inject drugs - United States. MMWR Morb Mortal Wkly Rep. 2016;65(47):1336\u201342.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"50","key":"3408_CR3","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.15585\/mmwr.mm6450a3","volume":"64","author":"RA Rudd","year":"2016","unstructured":"Rudd RA, Aleshire N, Zibbell JE, Gladden RM. Increases in drug and opioid overdose deaths \u2014 United States, 2000\u20132014. Morbidity and Mortality Weekly Report (MMWR). 2016;64(50):1378\u201382.","journal-title":"Morbidity and Mortality Weekly Report (MMWR)"},{"issue":"3","key":"3408_CR4","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/QAI.0000000000001098","volume":"73","author":"MM Van Handel","year":"2016","unstructured":"Van Handel MM, Rose CE, Hallisey EJ, Kolling JL, Zibbell JE, Lewis B, Bohm MK, Jones CM, Flanagan BE, Siddiqi AE, Iqbal K, Dent AL, Mermin JH, McCray E, Ward JW, Brooks JT. County-level vulnerability assessment for rapid dissemination of HIV or HCV infections among persons who inject drugs, United States. J Acquir Immune Defic Syndr. 2016;73(3):323\u201331.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"17","key":"3408_CR5","first-page":"453","volume":"64","author":"JE Zibbell","year":"2015","unstructured":"Zibbell JE, Iqbal K, Patel RC, Suryaprasad A, Sanders KJ, Moore-Moravian L, Serrecchia J, Blankenship S, Ward JW, Holtzman D, Centers for Disease Control and Prevention (CDC). Increases in hepatitis C virus infection related to injection drug use among persons aged. MMWR Morb Mortal Wkly Rep. 2015;64(17):453\u20138.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"22","key":"3408_CR6","doi-asserted-by":"publisher","first-page":"569","DOI":"10.15585\/mmwr.mm6622a1","volume":"66","author":"AT Fleischauer","year":"2017","unstructured":"Fleischauer AT, Ruhl L, Rhea S, Barnes E. Hospitalizations for endocarditis and associated health care costs among persons with diagnosed drug dependence - North Carolina, 2010-2015. MMWR Morb Mortal Wkly Rep. 2017;66(22):569\u201373.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"3408_CR7","first-page":"90","volume":"24","author":"DM Janowicz","year":"2016","unstructured":"Janowicz DM. HIV transmission and injection drug use: lessons from the Indiana outbreak. Top Antivir Med. 2016;24(2):90\u20132.","journal-title":"Top Antivir Med"},{"issue":"2","key":"3408_CR8","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1086\/313664","volume":"30","author":"JA Frontera","year":"2000","unstructured":"Frontera JA, Gradon JD. Right-side endocarditis in injection drug users: review of proposed mechanisms of pathogenesis. Clin Infect Dis. 2000;30(2):374\u20139.","journal-title":"Clin Infect Dis"},{"issue":"18","key":"3408_CR9","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1056\/NEJMra010082","volume":"345","author":"E Mylonakis","year":"2001","unstructured":"Mylonakis E, Calderwood SB. Infective endocarditis in adults. N Engl J Med. 2001;345(18):1318\u201330.","journal-title":"N Engl J Med"},{"issue":"2","key":"3408_CR10","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0733-8651(03)00025-0","volume":"21","author":"JM Miro","year":"2003","unstructured":"Miro JM, del Rio A, Mestres CA. Infective endocarditis and cardiac surgery in intravenous drug abusers and HIV-1 infected patients. Cardiol Clin. 2003;21(2):167\u201384 v-vi.","journal-title":"Cardiol Clin"},{"issue":"1","key":"3408_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.athoracsur.2011.08.016","volume":"93","author":"DG Rabkin","year":"2012","unstructured":"Rabkin DG, Mokadam NA, Miller DW, Goetz RR, Verrier ED, Aldea GS. Long-term outcome for the surgical treatment of infective endocarditis with a focus on intravenous drug users. Ann Thorac Surg. 2012;93(1):51\u20137.","journal-title":"Ann Thorac Surg"},{"issue":"5","key":"3408_CR12","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1093\/icvts\/ivv397","volume":"22","author":"OB Osterdal","year":"2016","unstructured":"Osterdal OB, Salminen PR, Jordal S, Sjursen H, Wendelbo O, Haaverstad R. Cardiac surgery for infective endocarditis in patients with intravenous drug use. Interact Cardiovasc Thorac Surg. 2016;22(5):633\u201340.","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"3408_CR13","unstructured":"Virginia Department of Health [\n                    http:\/\/www.vdh.virginia.gov\/home\/the-opioid-addiction-crisis-is-a-public-health-emergency-in-virginia\/#a1\n                    \n                  ]. Accessed 14 Apr 2017."},{"issue":"6","key":"3408_CR14","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.amjms.2016.08.010","volume":"352","author":"L Hartman","year":"2016","unstructured":"Hartman L, Barnes E, Bachmann L, Schafer K, Lovato J, Files DC. Opiate injection-associated infective endocarditis in the southeastern United States. Am J Med Sci. 2016;352(6):603\u20138.","journal-title":"Am J Med Sci"},{"issue":"4","key":"3408_CR15","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/dar.12228","volume":"34","author":"MK Tung","year":"2015","unstructured":"Tung MK, Light M, Giri R, Lane S, Appelbe A, Harvey C, Athan E. Evolving epidemiology of injecting drug use-associated infective endocarditis: a regional Centre experience. Drug Alcohol Rev. 2015;34(4):412\u20137.","journal-title":"Drug Alcohol Rev"},{"issue":"6","key":"3408_CR16","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.amjms.2016.10.002","volume":"352","author":"SW Keeshin","year":"2016","unstructured":"Keeshin SW, Feinberg J. Endocarditis as a marker for new epidemics of injection drug use. Am J Med Sci. 2016;352(6):609\u201314.","journal-title":"Am J Med Sci"},{"issue":"3","key":"3408_CR17","doi-asserted-by":"publisher","first-page":"ofw157","DOI":"10.1093\/ofid\/ofw157","volume":"3","author":"AG Wurcel","year":"2016","unstructured":"Wurcel AG, Anderson JE, Chui KK, Skinner S, Knox TA, Snydman DR, Stopka TJ. Increasing infectious endocarditis admissions among young people who inject drugs. Open Forum Infect Dis. 2016;3(3):ofw157.","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"3408_CR18","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.hlc.2017.03.166","volume":"27","author":"A Wright","year":"2018","unstructured":"Wright A, Otome O, Harvey C, Bowe S, Athan E. The current epidemiology of injecting drug use-associated infective endocarditis in Victoria, Australia in the midst of increasing crystal methamphetamine use. Heart Lung Circ. 2018;27(4):484\u20138.","journal-title":"Heart Lung Circ"},{"key":"3408_CR19","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.drugpo.2016.08.016","volume":"39","author":"K Adamson","year":"2017","unstructured":"Adamson K, Jackson L, Gahagan J. Young people and injection drug use: is there a need to expand harm reduction services and support? Int J Drug Policy. 2017;39:14\u201320.","journal-title":"Int J Drug Policy"},{"issue":"9","key":"3408_CR20","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/j.addbeh.2005.12.007","volume":"31","author":"JB Unger","year":"2006","unstructured":"Unger JB, Kipke MD, De Rosa CJ, Hyde J, Ritt-Olson A, Montgomery S. Needle-sharing among young IV drug users and their social network members: the influence of the injection partner's characteristics on HIV risk behavior. Addict Behav. 2006;31(9):1607\u201318.","journal-title":"Addict Behav"},{"issue":"4","key":"3408_CR21","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/ADM.0b013e318294b1eb","volume":"7","author":"C Jewell","year":"2013","unstructured":"Jewell C, Weaver M, Sgroi C, Anderson K, Sayeed Z. Residential addiction treatment for injection drug users requiring intravenous antibiotics: a cost-reduction strategy. J Addict Med. 2013;7(4):271\u20136.","journal-title":"J Addict Med"},{"issue":"3","key":"3408_CR22","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/ajad.12349","volume":"25","author":"J Suzuki","year":"2016","unstructured":"Suzuki J. Medication-assisted treatment for hospitalized patients with intravenous-drug-use related infective endocarditis. Am J Addict. 2016;25(3):191\u20134.","journal-title":"Am J Addict"},{"issue":"3","key":"3408_CR23","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1001\/journalofethics.2016.18.3.hlaw1-1603","volume":"18","author":"R Weinmeyer","year":"2016","unstructured":"Weinmeyer R. Needle exchange Programs' status in US politics. AMA J Ethics. 2016;18(3):252\u20137.","journal-title":"AMA J Ethics"},{"key":"3408_CR24","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1747-597X-9-31","volume":"9","author":"E Jozaghi","year":"2014","unstructured":"Jozaghi E, Reid AA, Andresen MA, Juneau A. A cost-benefit\/cost-effectiveness analysis of proposed supervised injection facilities in Ottawa, Canada. Subst Abuse Treat Prev Policy. 2014;9:31 597X-9-31.","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"17","key":"3408_CR25","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1097\/QAD.0b013e3283578b5d","volume":"26","author":"JA Kwon","year":"2012","unstructured":"Kwon JA, Anderson J, Kerr CC, Thein HH, Zhang L, Iversen J, Dore GJ, Kaldor JM, Law MG, Maher L, Wilson DP. Estimating the cost-effectiveness of needle-syringe programs in Australia. AIDS. 2012;26(17):2201\u201310.","journal-title":"AIDS"},{"issue":"11","key":"3408_CR26","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1007\/s10461-014-0789-9","volume":"18","author":"TQ Nguyen","year":"2014","unstructured":"Nguyen TQ, Weir BW, Des Jarlais DC, Pinkerton SD, Holtgrave DR. Syringe exchange in the United States: a national level economic evaluation of hypothetical increases in investment. AIDS Behav. 2014;18(11):2144\u201355.","journal-title":"AIDS Behav"},{"issue":"10","key":"3408_CR27","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1176\/appi.ps.201400140","volume":"65","author":"CL Barry","year":"2014","unstructured":"Barry CL, McGinty EE, Pescosolido BA, Goldman HH. Stigma, discrimination, treatment effectiveness, and policy: public views about drug addiction and mental illness. Psychiatr Serv. 2014;65(10):1269\u201372.","journal-title":"Psychiatr Serv"},{"issue":"4","key":"3408_CR28","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1086\/313753","volume":"30","author":"JS Li","year":"2000","unstructured":"Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, Bashore T, Corey GR. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30(4):633\u20138.","journal-title":"Clin Infect Dis"},{"key":"3408_CR29","unstructured":"Virginia Department of Health [\n                    http:\/\/www.vdh.virginia.gov\/health-equity\/division-of-rural-health\/\n                    \n                  ]. Accessed 28 May 2018."},{"key":"3408_CR30","unstructured":"Hoen B, Alla F, Selton-Suty C, Beguinot I, Bouvet A, Briancon S, Casalta JP, Danchin N, Delahaye F, Etienne J, Le Moing V, Leport C, Mainardi JL, Ruimy R, Vandenesch F, Association pour l'Etude et la prevention de l'Endocardite Infectieuse (AEPEI) study group: Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA 2002, 288(1):75\u201381."},{"key":"3408_CR31","unstructured":"Center for Disease Control and Prevention [\n                    https:\/\/www.cdc.gov\/drugoverdose\/data\/prescribing.html\n                    \n                  ]."},{"key":"3408_CR32","unstructured":"Virginia Department of Health [\n                    http:\/\/www.vdh.virginia.gov\/content\/uploads\/sites\/10\/2016\/06\/Virginia-Hepatitis-C-Epidemiologic-Profile-2016.pdf\n                    \n                  ]. Accessed 14 Apr 2017."},{"key":"3408_CR33","unstructured":"Virginia's Legislative Information System [\n                    https:\/\/lis.virginia.gov\/cgi-bin\/legp604.exe?171+ful+HB2317\n                    \n                  ]. Accessed 28 Sept 2018."},{"issue":"8","key":"3408_CR34","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.2105\/AJPH.2015.302664","volume":"105","author":"Christopher M. Jones","year":"2015","unstructured":"Jones CM, Campopiano M, Baldwin G, McCance-Katz E. National and State Treatment Need and Capacity for Opioid Agonist Medication-Assisted Treatment. Am J Public Health. 2015;105(8):e55\u201363.","journal-title":"American Journal of Public Health"},{"issue":"4","key":"3408_CR35","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1001\/jamapsychiatry.2013.4450","volume":"71","author":"SC Sigmon","year":"2014","unstructured":"Sigmon SC. Access to treatment for opioid dependence in rural America: challenges and future directions. JAMA Psychiatry. 2014;71(4):359\u201360.","journal-title":"JAMA Psychiatry"},{"issue":"5","key":"3408_CR36","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1377\/hlthaff.2014.1330","volume":"34","author":"C Andrews","year":"2015","unstructured":"Andrews C, Abraham A, Grogan CM, Pollack HA, Bersamira C, Humphreys K, Friedmann P. Despite resources from the ACA, Most states do little to help addiction treatment programs implement health care reform. Health Aff (Millwood). 2015;34(5):828\u201335.","journal-title":"Health Aff (Millwood)"},{"issue":"5","key":"3408_CR37","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.amjmed.2015.09.024","volume":"129","author":"ES Rosenthal","year":"2016","unstructured":"Rosenthal ES, Karchmer AW, Theisen-Toupal J, Castillo RA, Rowley CF. Suboptimal addiction interventions for patients hospitalized with injection drug use-associated infective endocarditis. Am J Med. 2016;129(5):481\u20135.","journal-title":"Am J Med"},{"issue":"10","key":"3408_CR38","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.3109\/10826084.2014.901383","volume":"49","author":"C Taplin","year":"2014","unstructured":"Taplin C, Saddichha S, Li K, Krausz MR. Family history of alcohol and drug abuse, childhood trauma, and age of first drug injection. Subst Use Misuse. 2014;49(10):1311\u20136.","journal-title":"Subst Use Misuse"},{"key":"3408_CR39","unstructured":"Centers for Disease Control and Prevention [\n                    https:\/\/www.cdc.gov\/hiv\/pdf\/guidelines\/PrEPguidelines2014.pdf\n                    \n                  ]. Accessed 15 Feb 2017."},{"issue":"18","key":"3408_CR40","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1111\/j.1365-2702.2007.02266.x","volume":"17","author":"R Ford","year":"2008","unstructured":"Ford R, Bammer G, Becker N. The determinants of nurses' therapeutic attitude to patients who use illicit drugs and implications for workforce development. J Clin Nurs. 2008;17(18):2452\u201362.","journal-title":"J Clin Nurs"},{"key":"3408_CR41","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.socscimed.2014.12.010","volume":"126","author":"EE McGinty","year":"2015","unstructured":"McGinty EE, Goldman HH, Pescosolido B, Barry CL. Portraying mental illness and drug addiction as treatable health conditions: effects of a randomized experiment on stigma and discrimination. Soc Sci Med. 2015;126:73\u201385.","journal-title":"Soc Sci Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3408-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-018-3408-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3408-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T11:35:37Z","timestamp":1589456137000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-018-3408-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,24]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3408"],"URL":"https:\/\/doi.org\/10.1186\/s12879-018-3408-y","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,24]]},"assertion":[{"value":"6 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval was obtained through University of Virginia\u2019s Institutional Review Board (IBR_HSR #19238). No consent to participate was obtained as no data considered to be patient identifiers was collected.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"532"}}